Subscription-Based Pricing for Lenacapavir—Learning From Hepatitis C and Cabotegravir

This Viewpoint discusses ways in which payer license agreements can facilitate widespread lenacapavir use, a key step in ending the HIV epidemic.

Authors

Institutions

Publication Details

Journal
JAMA
Published
2026-01-07
DOI
https://doi.org/10.1001/jama.2025.24404
Primary Topic
Hepatitis C virus research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Subscription-Based Pricing for Lenacapavir—Learning From Hepatitis C and Cabotegravir

Charles Flexner, M. Rose, Victor Roy
JAMA
Hepatitis C virus research
article

Subscription-Based Pricing for Lenacapavir—Learning From Hepatitis C and Cabotegravir

Charles Flexner, M. Rose, Victor Roy
article en

Abstract

This Viewpoint discusses ways in which payer license agreements can facilitate widespread lenacapavir use, a key step in ending the HIV epidemic.

JAMAVol. 335(6)
Johns Hopkins University (US), Johns Hopkins Medicine (US), Institute for Community Health (US)
Good health and well-being
Openalex Percentile: Top 95%
Hepatitis C virus research
DOISourceOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Subscription-Based Pricing for Lenacapavir—Learning From Hepatitis C and Cabotegravir — Charles Flexner, M. Rose, et al. · JAMA (2026) | TGRS Research Map | TGRS